should we buy more.
ask yourself am I a growth investor if yes well maybe we should.
should check the stats DYR.
some stats: p/e ratio40%
eps growth estimated to be nxt 2yrs 34% 23%
price/book value is high at 6.63 times
debt /equity is low
divi payout around 55% ( is low but shows CTD are growing the business)
net profit still growing
revenue growth
so looks ok for next 2 years
management still nimble
- Forums
- ASX - By Stock
- CTD
- One of top stocks
One of top stocks, page-15
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CTD (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.91 |
Change
0.280(2.22%) |
Mkt cap ! $1.871B |
Open | High | Low | Value | Volume |
$12.50 | $12.97 | $12.42 | $3.148M | 245.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 2613 | $12.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.92 | 1717 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 743 | 12.910 |
9 | 2052 | 12.900 |
6 | 1089 | 12.890 |
6 | 1408 | 12.880 |
6 | 4756 | 12.870 |
Price($) | Vol. | No. |
---|---|---|
12.920 | 364 | 6 |
12.930 | 1387 | 7 |
12.940 | 5479 | 12 |
12.950 | 2730 | 9 |
12.960 | 1625 | 4 |
Last trade - 15.48pm 13/11/2024 (20 minute delay) ? |
Featured News
CTD (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online